BOD (psychedelic)

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
BOD
4-methyl-2,5,beta-trimethoxy-phenethylamine.svg
BOD-3d-sticks.png
Names
IUPAC name
2-(2,5-Dimethoxy-4-methylphenyl)-2-methoxyethanamine
Other names
4-Methyl-2,5,β-trimethoxyphenethylamine
2-(4-Methyl-2,5,β-trimethoxyphenyl)ethanamine
Identifiers
3D model (JSmol)
ChemSpider
Properties
C12H19NO3
Molar mass 225.288 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

BOD (4-methyl-2,5,beta-trimethoxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-methoxy analog of 2C-D. BOD was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–25 mg, and the duration listed as 8–16 hours.[1] BOD produces strongly distorted open-eye visuals, and some closed-eye visuals. It also has an entheogenic effect and produces humor.[2] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOD.

Legality[edit]

United Kingdom[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]

See also[edit]

References[edit]

  1. ^ BOD Entry in PiHKAL
  2. ^ Shulgin, Alexander; Ann Shulgin (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  3. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.